Your institution may have access to this item. Find your institution then sign in to continue.
Title
Phase II study of radiopeptide 177Lu-octreotate and capecitabine therapy of progressive disseminated neuroendocrine tumours.
Authors
Claringbold, Phillip G; Brayshaw, Paul A; Price, Richard A; Turner, J Harvey
Abstract
In this phase II study we investigated the safety and efficacy of combination capecitabine and (177)Lu-octreotate for the treatment of disseminated, progressive, unresectable neuroendocrine tumours (NETs).
Publication
European journal of nuclear medicine and molecular imaging, 2011, Vol 38, Issue 2, p302